Proposed Collection; Comment Request; Monitoring and Evaluation of the NIDA Goes Back to School National Dissemination Campaign, 4273-4274 [07-357]

Download as PDF Federal Register / Vol. 72, No. 19 / Tuesday, January 30, 2007 / Notices and sharing of lessons learned. They are world leaders in this area and have worked with other programs in similar settings to improve chronic illness systems of care for underserved and vulnerable populations, including the Health Resources and Services Administration/Bureau of Primary Health Care’s health center program for eight years. The IHI’s intellectual capital and operational capacity are essential to the IHS. The IHI has the resources and access to an international network of experts in the area of chronic disease management and implementing chronic care models in various settings. Most other improvement agencies and organizations focus on specific steps and methodologies while IHI takes a much more comprehensive and strategic approach to improvement. Over the past 15 years they have become the recognized world leader in system change in healthcare. They have moved beyond the specifics of software into process development using a variety of techniques to make the best use of technologies and existing organizational capabilities. Their methodologies include improvement advisors who act as peer to peer coaches for organizations implementing change. This personal approach and the IHI’s considerable expertise are critical to expand existing Indian Country efforts, where personal connection and effective relationships are often the difference between project success and failure. This single source cooperative agreement will allow IHS to expedite learning from their organization as well as expedite access to IHI’s vast network of strategic partners. ycherry on PROD1PC64 with NOTICES III. Award Information Type of Awards: Cooperative Agreement. Estimated Funds Available: The award is for three years. For year one $600,000 is available and for years two and three—$800,000 is available for each year for a continuation award. Award under this announcement is subject to availability of funds. Anticipated Number of Awards: One single source award will be made under the Program. Project Period: February 16, 2007– February 15, 2010. Award Amount: $600,000 in year 1; $800,000 in years 2 and 3. For information regarding the notification, please contact: Candace M. Jones, MPH, National Programs (NPABQ), 5300 Homestead Road, NE., VerDate Aug<31>2005 15:36 Jan 29, 2007 Jkt 211001 Albuquerque, NM 87110, 505–248–4961 or candace.jones@ihs.gov. Electronic Submission: The preferred method for receipt of applications is electronic submission through Grants.gov. Please refer to the following links for complete application instructions: applicant package may be found in Grants.gov (www.grants.gov) or https://www.ihs.gov/ NonMedicalPrograms/gogp/ gogplfund.asp. 4273 per year. These large numbers indicate that the dissemination reach is considerable. The pattern of requests also indicates that the number of requests increases dramatically in the early weeks after a dissemination activity is launched. The purpose of this information collection is to determine the level of use by school personnel and community leaders who request the NGBTS materials, and if there is a difference in use level between those Dated: January 18, 2007. requestors responding to a campaign Robert G. McSwain, activity and those requestors who were Deputy Director, Indian Health Service. not reached by campaign activities. The information will identify barriers to the [FR Doc. 07–386 Filed 1–29–07; 8:45 am] use of the materials among these BILLING CODE 4165–16–M occupational groups and the populations they serve. It will help DEPARTMENT OF HEALTH AND make the materials more productive in HUMAN SERVICES raising the awareness of the harms from substance abuse among children, youth, The National Institutes of Health and parents. It will be used to refine the focus of the dissemination activities, so Proposed Collection; Comment Request; Monitoring and Evaluation of that dissemination resources are used more productively. The information will the NIDA Goes Back to School be collected from requestors who have National Dissemination Campaign requested NIDA NGBTS materials using Summary: In compliance with Section the requestor forms from the NIDA site, 3506(c)(2)(A) of the Paperwork from October 2003 to September 2005. Reduction Act of 1995 concerning All information collection in the opportunity for public comment on evaluation will be conducted on-line. proposed collection of information, the The estimated total time for a survey is National Institute on Drug Abuse 5 minutes. Prior to the monitoring and (NIDA), the National Institutes of Health evaluation study, the information (NIH) will publish periodic summaries collection instruments will be pilotof proposed projects to be submitted to tested via telephone interview format, the Office of Management and Budget with a sample of 8 individuals who (OMB) for review and approval. have requested these materials during Proposed Collection: Title: Monitoring the chosen study years. The surveys will and Evaluation of the NIDA Goes Back include the following elements: (1) Use to School National Dissemination of the NGBTS materials, (2) Opinion of Campaign. Type of Information Collection Request: New. Need and Use the NGBTS materials, (3) Respondent information on gender, present of Information Collection: This is a occupation and its duration, (4) request for a one-time clearance to Background information on the school collect information on the use of the or Organization/Community. Frequency NIDA Goes Back to School (NGBTS) of Response: This project will be dissemination materials that can be requested by interested persons from the conducted once. Affected Public: School personnel, and Community Leaders who NIDA Internet site. The National have requested the NGBTS materials. Institute on Drug Abuse (NIDA) Type of Respondent: School personnel, launched an initiative to increase and Community Leaders who have awareness of the Institute and its mission to bring the power of science to requested the NGBTS materials from the bear on the treatment and prevention of NIDA site. Estimated Total Annual Number of Respondents: 400. Estimated drug abuse and addiction. NIDA has Number of Responses per Respondent: been developing science education 1. Average Burden Hours per Response: materials for grades K–12 for use by .08. Estimated Total Annual Burden students, teachers, parents, school Hours Requested: 32.0. There are no counselors, school health educators, Capital Costs to report. There are no school resources officers, community Operating or Maintenance Costs to organizers, and state and local report. The estimated annualized government agencies. The number of burden is summarized below. requestors has been an average of 7,500 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\30JAN1.SGM 30JAN1 4274 Federal Register / Vol. 72, No. 19 / Tuesday, January 30, 2007 / Notices Type of respondents Number of respondents Frequency of response Average burden hours per response Estimated total burden hours requested Requesters—School Personnel ....................................................... Requestors—Community Leaders ................................................... 200 200 1 1 0.08 0.08 16 16 Total .......................................................................................... 400 ............................ ............................ 32 Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plans, contact Brian Marquis, Project Officer, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 5216, Bethesda, MD 20892, or call non-toll-free number 301– 443–1124; fax 301–443–7397; or by email to bmarquis@/nida.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60-days of the date of this publication. Donna Jones, Budget Officer & Acting Associate Director for Management, National Institute on Drug Abuse. [FR Doc. 07–357 Filed 1–29–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. ycherry on PROD1PC64 with NOTICES AGENCY: SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious VerDate Aug<31>2005 15:36 Jan 29, 2007 Jkt 211001 commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Megakaryocyte Potentiation Factor as a New Serum Tumor Marker for Mesothelioma Description of Technology: Mesothelin is a glycoprotein, whose expression has been largely restricted to mesothelial cells in normal tissues, although epithelial cells of the trachea, tonsil, fallopian tube, and kidney have shown immunoreactivity. Mesothelin has been shown to be expressed in several cancers including mesothelioma, lung cancer, pancreatic carcinomas, gastric carcinomas and ovarian carcinomas, and has the potential of being used as a tumor marker and a novel target for the development of new treatments. Mesothelin precursor protein is a 69 kDa protein that is proteolytically cleaved into two products, the megakaryocyte potentiation factor (MPF) and mesothelin. MPF is a 33 kDa soluble protein that is shed into the blood stream of patients with mesotheliomas and other tumors including ovarian and pancreatic and thus can be used as a serum marker for the diagnosis of mesothelin expressing cancers. This invention describes the generation of monoclonal antibodies to MPF. The antibodies can be useful for diagnosing mesotheliomas and other cancers. Additionally, it can be used by the oncological research community as a research tool. Applications: New monoclonal antibodies against MPF; A new PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 monoclonal antibody against MPF that can be used for diagnosis method for mesotheliomas and other cancers including ovarian and pancreatic by detecting MPF in serum of patients. Market: Cancer diagnostic market is projected to grow to approximately $8B in the next 5 years; Potential as a research tool for oncology research market. Inventor: Ira H. Pastan et al. (NCI). Publication: M Onda et al. Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma. Clin Cancer Res. 2006 Jul 15;12 (14 Pt 1):4225–4231. Patent Status: HHS Reference No. E– 293–2006/0—Research Tool. Licensing Status: Available for licensing under a Biological Materials license. Licensing Contact: Jesse S. Kindra, J.D.; 301/435–5559; kindraj@mail.nih.gov. Enriched Natural Killer Cells for Adoptive Infusion Cancer Therapy Description of Technology: Immunotherapy has taken a lead among the new cancer therapeutic approaches. It is one of the most promising new therapeutic approaches that exploit the innate immune mechanism of an individual to fight against a certain disease. Natural killer (NK) cells are a form of cytotoxic lymphocytes which constitute a major portion of the innate immune system. NK cells have tumor cytotoxic properties independent of tumor specific antigens and have been shown in murine models to control and prevent tumor growth and dissemination. Inactivation of NK cells potentially allows cancer cells to evade host NKcell-mediated immunity. Ligation of killer immunoglobulin like receptors (KIRs) by MHC class I on both normal and malignant tissues suppresses the function of NK cells. The present invention relates to treating cancer and other hyperproliferative disorders by administering an enriched composition of allogeneic or autologous (KIR/KIR ligand incompatible) NK cell population. This enriched composition can potentially override the inactivation E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 72, Number 19 (Tuesday, January 30, 2007)]
[Notices]
[Pages 4273-4274]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-357]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

The National Institutes of Health

Proposed Collection; Comment Request; Monitoring and Evaluation
of the NIDA Goes Back to School National Dissemination Campaign

Summary: In compliance with Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning opportunity for public comment on
proposed collection of information, the National Institute on Drug
Abuse (NIDA), the National Institutes of Health (NIH) will publish
periodic summaries of proposed projects to be submitted to the Office
of Management and Budget (OMB) for review and approval.
Proposed Collection: Title: Monitoring and Evaluation of the NIDA
Goes Back to School National Dissemination Campaign. Type of
Information Collection Request: New. Need and Use of Information
Collection: This is a request for a one-time clearance to collect
information on the use of the NIDA Goes Back to School (NGBTS)
dissemination materials that can be requested by interested persons
from the NIDA Internet site. The National Institute on Drug Abuse
(NIDA) launched an initiative to increase awareness of the Institute
and its mission to bring the power of science to bear on the treatment
and prevention of drug abuse and addiction. NIDA has been developing
science education materials for grades K-12 for use by students,
teachers, parents, school counselors, school health educators, school
resources officers, community organizers, and state and local
government agencies. The number of requestors has been an average of
7,500 per year. These large numbers indicate that the dissemination
reach is considerable. The pattern of requests also indicates that the
number of requests increases dramatically in the early weeks after a
dissemination activity is launched. The purpose of this information
collection is to determine the level of use by school personnel and
community leaders who request the NGBTS materials, and if there is a
difference in use level between those requestors responding to a
campaign activity and those requestors who were not reached by campaign
activities. The information will identify barriers to the use of the
materials among these occupational groups and the populations they
serve. It will help make the materials more productive in raising the
awareness of the harms from substance abuse among children, youth, and
parents. It will be used to refine the focus of the dissemination
activities, so that dissemination resources are used more productively.
The information will be collected from requestors who have requested
NIDA NGBTS materials using the requestor forms from the NIDA site, from
October 2003 to September 2005. All information collection in the
evaluation will be conducted on-line. The estimated total time for a
survey is 5 minutes. Prior to the monitoring and evaluation study, the
information collection instruments will be pilot-tested via telephone
interview format, with a sample of 8 individuals who have requested
these materials during the chosen study years. The surveys will include
the following elements: (1) Use of the NGBTS materials, (2) Opinion of
the NGBTS materials, (3) Respondent information on gender, present
occupation and its duration, (4) Background information on the school
or Organization/Community. Frequency of Response: This project will be
conducted once. Affected Public: School personnel, and Community
Leaders who have requested the NGBTS materials. Type of Respondent:
School personnel, and Community Leaders who have requested the NGBTS
materials from the NIDA site. Estimated Total Annual Number of
Respondents: 400. Estimated Number of Responses per Respondent: 1.
Average Burden Hours per Response: .08. Estimated Total Annual Burden
Hours Requested: 32.0. There are no Capital Costs to report. There are
no Operating or Maintenance Costs to report. The estimated annualized
burden is summarized below.

[[Page 4274]]

----------------------------------------------------------------------------------------------------------------
Average burden Estimated total
Type of respondents Number of Frequency of hours per burden hours
respondents response response requested
----------------------------------------------------------------------------------------------------------------
Requesters--School Personnel........ 200 1 0.08 16
Requestors--Community Leaders....... 200 1 0.08 16
---------------------------------------------------------------------------
Total........................... 400 ................. ................. 32
----------------------------------------------------------------------------------------------------------------

Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information shall have practical utility; (2) the
accuracy of the agency's estimate of the burden of the proposed
collection of information; (3) ways to enhance the quality, utility,
and clarity of the information to be collected; and (4) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.

FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection
plans, contact Brian Marquis, Project Officer, National Institute on
Drug Abuse, 6001 Executive Boulevard, Room 5216, Bethesda, MD 20892, or
call non-toll-free number 301-443-1124; fax 301-443-7397; or by e-mail
to bmarquis@/nida.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60-days
of the date of this publication.

Donna Jones,
Budget Officer & Acting Associate Director for Management, National
Institute on Drug Abuse.
[FR Doc. 07-357 Filed 1-29-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.